1. Home
  2. YY vs HRMY Comparison

YY vs HRMY Comparison

Compare YY & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YY
  • HRMY
  • Stock Information
  • Founded
  • YY 2005
  • HRMY 2017
  • Country
  • YY Singapore
  • HRMY United States
  • Employees
  • YY N/A
  • HRMY N/A
  • Industry
  • YY EDP Services
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • YY Technology
  • HRMY Health Care
  • Exchange
  • YY Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • YY 1.9B
  • HRMY 2.0B
  • IPO Year
  • YY 2012
  • HRMY 2020
  • Fundamental
  • Price
  • YY $33.62
  • HRMY $33.05
  • Analyst Decision
  • YY Hold
  • HRMY Buy
  • Analyst Count
  • YY 3
  • HRMY 9
  • Target Price
  • YY $35.00
  • HRMY $47.00
  • AVG Volume (30 Days)
  • YY 363.4K
  • HRMY 1.2M
  • Earning Date
  • YY 11-27-2024
  • HRMY 10-29-2024
  • Dividend Yield
  • YY 5.10%
  • HRMY N/A
  • EPS Growth
  • YY 5.68
  • HRMY N/A
  • EPS
  • YY 4.01
  • HRMY 2.11
  • Revenue
  • YY $2,266,596,000.00
  • HRMY $681,879,000.00
  • Revenue This Year
  • YY $1.86
  • HRMY $24.63
  • Revenue Next Year
  • YY $3.38
  • HRMY $18.04
  • P/E Ratio
  • YY $8.25
  • HRMY $15.69
  • Revenue Growth
  • YY N/A
  • HRMY 25.83
  • 52 Week Low
  • YY $27.88
  • HRMY $22.89
  • 52 Week High
  • YY $43.20
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • YY 45.07
  • HRMY 43.83
  • Support Level
  • YY $33.01
  • HRMY $31.02
  • Resistance Level
  • YY $34.46
  • HRMY $41.61
  • Average True Range (ATR)
  • YY 0.90
  • HRMY 1.77
  • MACD
  • YY -0.03
  • HRMY -0.19
  • Stochastic Oscillator
  • YY 30.65
  • HRMY 19.17

About YY JOYY Inc.

JOYY Inc is a global technology company offering comprehensive innovation capabilities. The company enables users to interact with others in real time. The group is actively exploring and expanding its global commerce Software-as-a-Service and solutions business. JOYY emphasizes technological innovation and is recognized in the industry for its significant number of patent applications and licenses.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

Share on Social Networks: